ASTIC TRIAL
Welcome to the ASTIC Trial
(Autologous Stem Cell Transplantation for Crohn's Disease)
A multicentre, prospective, randomised phase III study conducted by the European Crohn's and Colitis Organisation (ECCO), sponsored by the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
PLEASE NOTE: THIS TRIAL IS NOW CLOSED TO RECRUITMENT. INITIAL ANALYSIS DUE MARCH 2013
Study Update
|
Date
|
News
|
|
June 2012
|
Total number of patients transplanted is 38.
There are 4 patients left awaiting delayed transplants, the final of which is due Feb 2013
|
|
January 2012
|
Patient recruitment is halted. Initial analysis is due in a year.
A total of 45 patients have been randomised (of these 35 have been transplanted).
|
|
September 2011
|
A total of 39 patients have been randomised. Of these 27 patients have
been transplanted.
|
|
July 2011
|
Nottingham consents their 13th patient
|
|
November 2010
|
27 patients randomised and a further 9 patients consented to the trial.
A total of 17 patients have been transplanted.
|
|
September 2010
|
Belgium joins the ASTIC Trial.
Leuven Hospital consents 2 patients.
|
|
20 July 2010
|
Edinburgh consents 4 patients in a day!
This brings the total number of patients for this site to 6.
|
|
April 2010
|
BARTS and the London consent their first patient.
|
|
January 2010
|
All approvals completed for Switzerland; the first patient enters the trial in Zurich.
|
|
July 2009
|
14 patients now consented into the trial, with 7 transplants complete.
Sites with patients in trial include:
|
|
November 2008
|
Barcelona Storms Ahead - well done to Elena Ricart and her team.
5 patients registered and a further patient for discussion.
|
|
July 2008
|
The first transplants take place in Nottingham and Barcelona.
|
|
February 2008
|
Three sites now recruiting.
Nottingham, Oxford and Barcelona have completed trial registration.
|
|
July 2008
|
First patient recruited in Nottingham
|
This study is funded by a grant from the Broad Medical Research Programme.
The Chief Investigator for the study is:
Professor Chris Hawkey, Nottingham Digestive Diseases Centre, University Hospital, Nottingham NG7 2UH, UK.
Email: cj.hawkey@nottingham.ac.uk
The Study Administration Office, who are co-ordinating the trial, can be contacted at:
ASTIC Study Administration Office, Nottingham Digestive Diseases Centre, University Hospital, Nottingham NG7 2UH, UK.
Email: astic@nottingham.ac.uk Tel: +44 (0) 115 8231079. Fax: +44 (0) 115 823 1409